InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-25.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Hassan Fred, Director. Officer active across 4 companies, notably BridgeBio Pharma, Inc.. In total, 17 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €1.2m. Activity tracked since 29 December 2021. The latest transaction was disclosed on 10 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hassan Fred
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
3,990 sharesCommon StockSEC:0001470831-26-000629:0
71,839 sharesCommon StockSEC:0000950103-26-003833:0
17,948 shares@ US$3.514.6% of flowCommon StockSEC:0000950103-26-003687:0
359,713 shares@ US$1.39100.0% of flowCommon StockSEC:0001493152-25-020221:0
6,589 shares0Common StockSEC:0000950170-25-089647:0
36,206 shares@ US$1.745.1% of flowCommon StockSEC:0000950103-25-003518:0
8,067 sharesCommon StockSEC:0001493152-24-040899:0
44,055 shares@ US$1.435.1% of flowCommon StockSEC:0000950103-24-003955:0
106,837 sharesCommon StockSEC:0000950103-24-003746:0
570,345 shares@ US$1.7580.7% of flowCommon StockSEC:0000950103-23-012143:0
Canonical exit: 12 Nov 2023 (T+90)
2,123 sharesCommon StockSEC:0000899243-23-015758:0
2,123 shares0Common StockSEC:0001209191-23-031175:0
48,290 shares@ US$1.174.7% of flowCommon StockSEC:0000950103-23-004007:0
61,576 sharesCommon StockSEC:0000950103-23-003029:0
16,212 sharesCommon StockSEC:0000950103-22-005404:0
27,832 shares@ US$2.034.2% of flowCommon StockSEC:0000950103-22-003221:0
19,300 shares@ US$14.1653100.0% of flowCommon StockSEC:0000899243-22-000176:0
Canonical exit: 29 Mar 2022 (T+90)
17 of 17 declarations
About Hassan Fred
Hassan Fred is Administrateur and appears in 17 filings. Across the 17 tracked filings, the transactions span 2022-01-03 to 2026-06-24, with EUR 1156484 of buys and EUR 0 of sells; the main filings concern Precigen, INC., Cocrystal Pharma, Inc., and BridgeBio Pharma, Inc.
